Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : T/FIF Portfolio -- Ignore unavailable to you. Want to Upgrade?

To: Mike McFarland who wrote (458)	1/22/1999 5:02:00 PM
From: Atticus	Read Replies (1) \| Respond to of 1073

biz.yahoo.com Will this affect VRGN? I don't think it will help....

To: Mike McFarland who wrote (458)	1/22/1999 6:19:00 PM
From: LLCF	Read Replies (1) \| Respond to of 1073

<Seems not be be any interest...much less hype. Boy do I have egg on my face...last night I was awfully confident, not so now.> Don't be so sure yet... give it a week. Funds don't run out like we do, they discuss, meet once a week and then do something. And traders, who do react right away dont't have a clue about this stuff (except us).... we'll see. DAK

To: Mike McFarland who wrote (458)	1/24/1999 10:29:00 PM
From: LLCF	Respond to of 1073

<a good near-term investment concept> Any reason no one is kicking around CEPH???? $200 mill mkt cap, $90 mill. in cash, and a newly approved drug that some think will sell $300 million once off label gets cranking. What gives? Any comments? I'm adding it to my portfolio. Small blurb by "Neuro": biz.yahoo.com DAK